Life Sciences, Health & Bioethics Articles
June 26, 2012
HEALTH AND BIOETHICS
American cancer patients are suffering from a critical shortage of certain life-saving drugs. Patricia Tereskerz and Ann Mills discuss how conflicts of interest ranging from Congress, to Medicare, to doctor-patient relationships may be to blame.
June 21, 2012
A new painless, non-invasive technology can improve visual perception in healthy people. Dr. Moreno looks at the implications of transcranial magnetic stimulation for the warfighter and beyond.
June 18, 2012
SCIENCE AND CIVIL RIGHTS
A recent study by Mark Regnerus claimed to find that children raised by same-sex couples turn out to have more problems as adults than those raised by heterosexual parents. Ilana Yurkiewicz explains why policymakers should ignore it.
May 29, 2012
Here’s a reboot of our popular timeline of stem cell research and policy over the past 40 years. From early fetal tissue research to the first successful human treatments, this timeline documents the progress in stem cell science, and the policies that have impeded or promoted it.
May 16, 2012
In Brüstle v. Greenpeace, the highest court in the European Union ruled that processes requiring the destruction of human embryos cannot be patented in the European Union. The shaky ethical footing of the decision will only muddy the water for stem cell research going forward.
May 10, 2012
Mind control, truth serums, and “guilt-free” super soldiers. Experts discuss the past, present, and future of brain research in the military and counterintelligence and the paper back edition of “Mind Wars.”
April 26, 2012
The White House today released the long-awaited National Bioeconomy Blueprint, which summarizes emergent trends in biotechnology, and contains five strategic imperatives for government policy moving forward.
April 16, 2012
The Chinese Army’s announcement of an alertness drug, dubbed “Night Eagle,” probably says more about China’s desire to expand its presence in the pharmaceutical industry than it says about China’s ability to develop truly novel drugs.
April 9, 2012
INVESTING IN SCIENCE
The failure of the deficit reduction “super committee” to come up with a compromise last fall triggered drastic automatic cuts to federal programs across the board. Gordon F. Tomaselli examines how these cuts will impact vital medical research.
February 27, 2012
We can’t let the search for “sexy” new drugs distract from the need for process improvement and supply chain security of old ones that have stood the test of time.
February 7, 2012
INVESTING IN SCIENCE
The genetic testing industry, with its great potential to not only improve health care outcomes but also create jobs, is a prime example of a government investment with positive return.
February 2, 2012
We need to rethink the legal framework that allows new industrial chemicals to enter the market every day without being tested for potential health impacts on humans.
January 5, 2012
The complementarity of sword and shield, arrow and armor, bullet and vest, and bomb and shelter is represented today by engineered viruses and engineered immune systems.
December 22, 2011
The National Science Advisory Board for Biosecurity asked two leading life science journals not to publish certain details about experiments done on the bird flu virus to make it even more contagious and potentially deadly, citing public safety concerns.
December 8, 2011
The federal decision to prevent teenagers from obtaining emergency contraception over the counter cuts to the core of the progressives idea that science should always trump politics.
A new report reviews the status of biotech innovation clusters across the country and the world. The report shows potential for biotech innovation and job creation in emerging clusters from Houston to Atlanta to Indianapolis if we can get the policy right.
December 1, 2011
Rooted deeply in historic fact, Dr. Jason Karlawish’s marvelous new book traces the peculiar career of 19th century clinician-turned-scientist Dr. William Beaumont, who became a scientific one-hit-wonder by exploiting the body of the man whose life he saved.
November 29, 2011
Ever wonder how many mice have to die to produce one peer-reviewed medical journal article? Or one new drug? And how much can we really learn about human physiology from mice or other animal experiments anyway? Daniel Engber has authored an excellent, three-part expose at Slate that answers these and other questions about the animal research industry.
November 21, 2011
Why do we have trouble defining what a “person” is? The answer may lie in human evolutionary antiquity, writes Jonathan Moreno in a Huffington Post op-ed.
November 20, 2011
Arthur Caplan reports on a closed-door meeting at the Vatican, where Church leadership made it clear it will continue to throw its ethical might and even its money into the debate about where to get stem cells and how best to study them.